# A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL)

> **NCT00073489** · PHASE2 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 23 (—)

## Conditions studied

- Chronic Lymphocytic Leukemia

## Interventions

- **DRUG:** OSI-461

## Key facts

- **NCT ID:** NCT00073489
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-05
- **Primary completion:** —
- **Final completion:** 2003-12
- **Target enrollment:** 23 (—)
- **Last updated:** 2011-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00073489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00073489, "A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL)". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00073489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*